CRISPR-cas systems are among the newest additions to gene editing and regulating tools, offering unlimited possibilities, with considerable potential in genetic medicine, agriculture, biotechnology and fundamental research. Thus, in principle, CRISPR-cas systems have application in targeting defective genes to cure hereditary disorders, improving crops and livestock, enhancing biotechnological production of proteins, enzymes and metabolites and in engineering model laboratory animals for a particular set of investigations.
We are delighted to announce our first CRISPR symposium at Oxford, which will be held on 23rd March at St Hilda’s College. This symposium will be one of the first international meetings at Oxford that will bring together the CRISPR community from both academia and industry to discuss and share new ideas and applications of CRISPR-cas systems in gene engineering.